# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-048971
Filing Date
2026-04-27
Accepted
2026-04-27 07:00:48
Documents
36
Period of Report
2026-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2612738d2_8k.htm iXBRL | 8-K | 33926
2 | EXHIBIT 99.1 | tm2612738d2_ex99-1.htm | EX-99.1 | 44623
3 | EXHIBIT 99.2 | tm2612738d2_ex99-2.htm | EX-99.2 | 25636
7 | GRAPHIC | tm2612738d2_ex99-2img001.jpg | GRAPHIC | 15826
8 | GRAPHIC | tm2612738d2_ex99-1img001.jpg | GRAPHIC | 87108
9 | GRAPHIC | tm2612738d2_ex99-1img002.jpg | GRAPHIC | 280296
10 | GRAPHIC | tm2612738d2_ex99-1img003.jpg | GRAPHIC | 179355
11 | GRAPHIC | tm2612738d2_ex99-1img004.jpg | GRAPHIC | 171738
12 | GRAPHIC | tm2612738d2_ex99-1img005.jpg | GRAPHIC | 149513
13 | GRAPHIC | tm2612738d2_ex99-1img006.jpg | GRAPHIC | 144250
14 | GRAPHIC | tm2612738d2_ex99-1img007.jpg | GRAPHIC | 82801
15 | GRAPHIC | tm2612738d2_ex99-1img008.jpg | GRAPHIC | 168920
16 | GRAPHIC | tm2612738d2_ex99-1img009.jpg | GRAPHIC | 159642
17 | GRAPHIC | tm2612738d2_ex99-1img010.jpg | GRAPHIC | 165955
18 | GRAPHIC | tm2612738d2_ex99-1img011.jpg | GRAPHIC | 77652
19 | GRAPHIC | tm2612738d2_ex99-1img012.jpg | GRAPHIC | 154465
20 | GRAPHIC | tm2612738d2_ex99-1img013.jpg | GRAPHIC | 141304
21 | GRAPHIC | tm2612738d2_ex99-1img014.jpg | GRAPHIC | 185416
22 | GRAPHIC | tm2612738d2_ex99-1img015.jpg | GRAPHIC | 131635
23 | GRAPHIC | tm2612738d2_ex99-1img016.jpg | GRAPHIC | 204815
24 | GRAPHIC | tm2612738d2_ex99-1img017.jpg | GRAPHIC | 81553
25 | GRAPHIC | tm2612738d2_ex99-1img018.jpg | GRAPHIC | 130471
26 | GRAPHIC | tm2612738d2_ex99-1img019.jpg | GRAPHIC | 151878
27 | GRAPHIC | tm2612738d2_ex99-1img020.jpg | GRAPHIC | 155374
28 | GRAPHIC | tm2612738d2_ex99-1img021.jpg | GRAPHIC | 141276
29 | GRAPHIC | tm2612738d2_ex99-1img022.jpg | GRAPHIC | 187611
| Complete submission text file | 0001104659-26-048971.txt |  | 4865156

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | sgmt-20260427.xsd | EX-101.SCH | 3011
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sgmt-20260427_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sgmt-20260427_pre.xml | EX-101.PRE | 22356
39 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2612738d2_8k_htm.xml | XML | 3343

Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 26896461
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)